Patient support made easier
With our robust patient support and savings program, your eligible patients have 2 ways to pay as little as a 
on their MIEBO prescription.
BlinkRx is an option that can help patients save time and money on their MIEBO prescriptions
LOW PRICE FOR MIEBO
BlinkRx works with your eligible patients’ insurance and applies available savings to their MIEBO prescription. No copay card needed.†
SIMPLE PATIENT EXPERIENCE
BlinkRx will send patients a text with the lowest available price so that they can immediately purchase their MIEBO Rx online or over the phone.
PRIOR AUTHORIZATION SUPPORT
BlinkRx services provide prior authorization support for MIEBO prescriptions, should your patients’ insurance require it.
AMPLE STOCKING
BlinkRx services the entire country, making MIEBO accessible for all patients.
FREE FAST DELIVERY
BlinkRx delivers MIEBO prescriptions for free from one of their licensed network pharmacies around the country.
DEDICATED CUSTOMER SUPPORT
BlinkRx has a team of pharmacists and technicians that are available to support you, your team, and your patients from onboarding to adherence.
Copay offers are also available outside of the BlinkRx program.
BlinkRx provides support for both Commercial and Medicare Part D patients
Eligible Commercially insured patients may pay as little as a
How it works:
STEP 1:
E-prescribe MIEBO to BlinkRx U.S. Boise, Idaho, from your EMR dropdown or send scripts by phone or fax.
STEP 2:
BlinkRx will contact your patients with a confidential text (usually within 15 minutes), determine their copay, assist with prior authorizations, and apply any available savings offers for eligible patients. The patient then pays online or by phone.
STEP 3:
Your patient’s MIEBO is delivered—shipping is free.
Prescribe 
through your EMR to BlinkRx U.S. Boise, Idaho.Contact BlinkRx by phone at 1-833-914-3856 1-833-914-3856 or fax at 1-866-585-4631
The MIEBO Copay Card is here to help your patients start saving
Eligible Commercially insured patients may pay as little as a
Interested in the copay card? Your patients can download or activate their copay card in a matter of minutes.
*Terms and Conditions apply. This offer is only valid for eligible patients with commercial insurance. This offer is not valid for patients whose prescriptions are reimbursed by any federal or state healthcare program, including Medicaid, Medicare, TRICARE, or any other federal or state healthcare program. This offer is valid in the US only. Patients may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Please see MIEBO.copaysavingsprogram.com for eligibility criteria and full Terms and Conditions.
INDICATION
MIEBO™ (perfluorohexyloctane ophthalmic solution) is a semifluorinated alkane indicated for the treatment of the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
- MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO
- Instruct patients to instill one drop of MIEBO into each eye four times daily
- The safety and efficacy in pediatric patients below the age of 18 have not been established
- The most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness)
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information for MIEBO.
You are now leaving MIEBO-ECP.com
You are now leaving the MIEBO ECP website and are going to a website that Bausch + Lomb does not operate and to which Bausch + Lomb’s Privacy Policy does not apply.
Bausch + Lomb is not responsible for the content, format, maintenance, or policies of the website you are about to visit and does not endorse or monitor any content on such website.
INDICATION AND IMPORTANT
SAFETY INFORMATION
INDICATION
MIEBO™ (perfluorohexyloctane ophthalmic solution) is a semifluorinated alkane indicated for the treatment of the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
- MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO
- Instruct patients to instill one drop of MIEBO into each eye four times daily
- The safety and efficacy in pediatric patients below the age of 18 have not been established
- The most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness)
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full prescribing Information for MIEBO.